Main Street Financial Solutions, LLC 23and Me Holding Co. Transaction History

Main Street Financial Solutions, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$0.36 - $0.61 $90 - $152	-250 Reduced 1.42%	17,338 $6,000
Q1 2024 Apr 22, 2024	SELL	$0.4 - $0.91 $40 - $91	-100 Reduced 0.57%	17,588 $9,000
Q4 2023 Feb 08, 2024	SELL	$0.71 - $0.97 $355 - $485	-500 Reduced 2.75%	17,688 $16,000
Q3 2023 Nov 02, 2023	BUY	$0.96 - $2.01 $4,396 - $9,205	4,580 Added 33.66%	18,188 $17,000
Q2 2023 Aug 04, 2023	SELL	$1.59 - $2.29 $477 - $687	-300 Reduced 2.16%	13,608 $23,000
Q4 2022 Feb 07, 2023	BUY	$2.06 - $3.47 $28,650 - $48,260	13,908 New	13,908 $30,000
Q3 2022 Oct 24, 2022	BUY	$2.6 - $5.12 $36,160 - $71,208	13,908 New	13,908 $40,000
Q1 2022 Apr 22, 2022	SELL	$3.28 - $7.12 $33,721 - $73,200	-10,281 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$6.55 - $13.25 $67,340 - $136,223	10,281 New	10,281 $68,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Main Street Financial Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Main Street Financial Solutions, LLC with notifications on news.